100000 Participants Needed

Biorepository for Cancer Research

Recruiting at 42 trial locations
MB
Overseen ByMary Baker
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Caris Science, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on collecting and storing biological samples, such as blood or tissue, to aid researchers in studying precision medicine. Precision medicine tailors medical treatment to individual characteristics, enhancing patient care. By participating, individuals contribute to research that may lead to better, more personalized treatments in the future. Those who are 18 or older and can provide informed consent are suitable for this trial. As an unphased trial, participants have the unique opportunity to contribute to foundational research that could significantly advance personalized medicine.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about the Caris Biorepository Research Protocol because it aims to collect and analyze biological specimens in a way that could unlock new insights into various diseases. Unlike other treatments that focus on addressing symptoms or specific conditions, this protocol emphasizes understanding the underlying biological factors and genetic markers that contribute to disease development and progression. By gathering and studying these specimens, scientists hope to identify new targets for drug development and personalize treatment strategies, potentially leading to more effective and tailored healthcare solutions in the future.

Who Is on the Research Team?

MO

Matthew Oberley, MD

Principal Investigator

Caris Life Sciences

Are You a Good Fit for This Trial?

Inclusion Criteria

Capacity to provide informed consent

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Biorepository Development

Development and implementation of a state-of-the-science Biorepository ensuring molecular integrity and clinical relevance of human biospecimens

35 years

Specimen Release and Research

Release of specimens from the biorepository for testing and research purposes, including cancer laboratory diagnostic tests

35 years

Follow-up

Participants are monitored for safety and effectiveness after specimen collection and research activities

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Biological Specimen Collection

Find a Clinic Near You

Who Is Running the Clinical Trial?

Caris Science, Inc.

Lead Sponsor

Trials
5
Recruited
126,000+